AB Science S.A. (EPA:AB)
1.276
-0.010 (-0.78%)
Oct 20, 2025, 1:39 PM CET
AB Science Revenue
AB Science had revenue of 515 thousand EUR in the half year ending June 30, 2025, with 14.96% growth. This brings the company's revenue in the last twelve months to 1.03 million, down -5.08% year-over-year. In the year 2024, AB Science had annual revenue of 1.07 million with 10.52% growth.
Revenue (ttm)
1.03M
Revenue Growth
-5.08%
P/S Ratio
88.24
Revenue / Employee
28.53K
Employees
39
Market Cap
90.62M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.07M | 102.00K | 10.52% |
Dec 31, 2023 | 970.00K | 12.00K | 1.25% |
Dec 31, 2022 | 958.00K | -649.00K | -40.39% |
Dec 31, 2021 | 1.61M | 24.00K | 1.52% |
Dec 31, 2020 | 1.58M | 12.00K | 0.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 45.74B |
EssilorLuxottica Société anonyme | 27.24B |
Eurofins Scientific SE | 7.14B |
emeis Société anonyme | 5.77B |
Clariane SE | 5.31B |
bioMérieux | 4.12B |
Ipsen | 3.76B |
Sartorius Stedim Biotech | 2.95B |
AB Science News
- 3 days ago - AB Science S.A. (ABSCF) Discusses Clinical Update on AB8939 Combined With Venetoclax for Refractory and Relapsed AML With Poor Genetics Transcript - Seeking Alpha
- 2 months ago - Market concentration is scary and it's all around AI, says AB's Jim Tierney - CNBC
- 3 months ago - AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS - Benzinga
- 3 months ago - 'Top priority is to grow portfolio of companies,' Investor AB CEO says - CNBC
- 3 months ago - AB Science announces the successful completion of a EUR 1.925 million private placement - Benzinga
- 6 months ago - Isaac Newton-inspired Crypto Defies Gravity, Soars 7600% Since The Year Began - Benzinga
- 7 months ago - Dow Erases Earlier Declines - Barron's
- 7 months ago - California introduces Bitcoin rights in amended digital assets bill - Cointelegraph